Skip to main content
SpringerLink
Log in

NPY in allergic and respiratory disorders

  • Chapter
The NPY Family of Peptides in Immune Disorders, Inflammation, Angiogenesis and Cancer

Part of the book series: Progress in Inflammation Research ((PIR))

  • 405 Accesses

Conclusion

There is an abundant literature available regarding the involvement of NPY in airway homeostasis. However, there is no NPY-related therapeutic agent yet available or under clinical development for the treatment of airway diseases. Several aspects regarding the role of NPY in the physiological control of airway function and immunological mechanisms suggest that the development of selective agonists and antagonist should have potential therapeutic applications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Proetz AW (1953) Respiratory air currents and their clinical aspects. J Laryngol Otol 67(1): 1–27

    PubMed  CAS  Google Scholar 

  2. Cole P (1954) Respiratory mucosal vascular responses, air conditioning and thermo regulation. J Laryngol Otol 68(9): 613–622

    PubMed  CAS  Google Scholar 

  3. Cole P (1954) Recordings of respiratory air temperature. J Laryngol Otol 68(5): 295–307

    PubMed  CAS  Google Scholar 

  4. Williams HL (1973) Nasal physiology. In: WB Saunders (ed): Otolaryngology. Philadelphia, p. 330

    Google Scholar 

  5. Barnes PJ, Baraniuk JN, Belvisi MG (1991) Neuropeptides in the respiratory tract. Part I. Am Rev Respir Dis 144: 1187–1198

    CAS  Google Scholar 

  6. Barnes PJ, Baraniuk JN, Belvisi MG (1991) Neuropeptides in the respiratory tract. Part II. Am Rev Respir Dis 144(6): 1391–1399

    PubMed  CAS  Google Scholar 

  7. Dahlström A, Fuxe K (1965) The adrenergic innervation of the nasal mucosa in certain mammals. Acta Otolaryngol 59: 65–72

    Google Scholar 

  8. Anggard A, Densert O (1974) Adrenergic innervation of the nasal mucosa in cat. A histological and physiological study. Acta Otolaryngol 78(3-4): 232–241

    PubMed  CAS  Google Scholar 

  9. Cauna N (1970) The fine structure of the arteriovenous anastomosis and its nerve supply in the human nasal respiratory mucosa. Anat Rec 168(1): 9–21

    Article  PubMed  CAS  Google Scholar 

  10. Cauna N (1970) Electron microscopy of the nasal vascular bed and its nerve supply. Ann Otol Rhinol Laryngol 79(3): 443–450

    PubMed  CAS  Google Scholar 

  11. von Euler US (1948) Identification of the sympathomimetic ergone in adrenergic nerves of cattle (Sympathetin N) with laevonoradrenaline. Acta Physiol Scand 16: 63–74

    Google Scholar 

  12. Tatemoto K, Carlquist M, Mutt V (1982) Neuropeptide Y — a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296(5858): 659–660

    Article  PubMed  CAS  Google Scholar 

  13. Lacroix JS, Stjarne P, Anggard A, Lundberg JM (1989) Sympathetic vascular control of the pig nasal mucosa (III): Co-release of noradrenaline and neuropeptide Y. Acta Physiol Scand 135(1): 17–28

    PubMed  CAS  Google Scholar 

  14. Lacroix JS, Anggard A, Hokfelt T, O’Hare MM, Fahrenkrug J, Lundberg JM (1990) Neuropeptide Y: presence in sympathetic and parasympathetic innervation of the nasal mucosa. Cell Tissue Res 259(1): 119–128

    Article  PubMed  CAS  Google Scholar 

  15. Baraniuk JN, Castellino S, Lundgren JD, Goff J, Mullol J, Merida M, Shelhamer JH, Kaliner MA (1990) Neuropeptide Y (NPY) in human nasal mucosa. Am J Respir Cell Mol Biol 3(2): 165–173

    PubMed  CAS  Google Scholar 

  16. Sheppard MN, Polak JM, Allen JM, Bloom SR (1984) Neuropeptide tyrosine (NPY): a newly discovered peptide is present in the mammalian respiratory tract. Thorax 39(5): 326–330

    PubMed  CAS  Google Scholar 

  17. Widdicombe JG (1991) Neural control of airway vasculature and edema. Am Rev Respir Dis 143(3 Pt 2): S18–S21

    PubMed  CAS  Google Scholar 

  18. Lacroix JS, Auberson S, Morel DR, Theodorsson E, Hokfelt T, Lundberg JM (1992) Vascular control of the pig nasal mucosa: distribution and effect of somatostatin in relation to noradrenaline and neuropeptide Y. Regul Pept 40(3): 373–387

    Article  PubMed  CAS  Google Scholar 

  19. Heppt W, Peiser C, Cryer A, Dinh QT, Zweng M, Witt C, Fischer A, Groneberg DA (2002) Innervation of human nasal mucosa in environmentally triggered hyperreflectoric rhinitis. J Occup Environ Med 44(10): 924–929

    PubMed  CAS  Google Scholar 

  20. Groneberg DA, Heppt W, Cryer A, Wussow A, Peiser C, Zweng M, Dinh QT, Witt C, Fischer A (2003) Toxic rhinitis-induced changes of human nasal mucosa innervation. Toxicol Pathol 31(3): 326–331

    PubMed  CAS  Google Scholar 

  21. Groneberg DA, Heppt W, Welker P, Peiser C, Dinh QT, Cryer A, Zweng M, Witt C, Fischer A (2003) Aspirin-sensitive rhinitis-associated changes in upper airway innervation. Eur Respir J 22(6): 986–991

    Article  PubMed  CAS  Google Scholar 

  22. Lacroix JS, Stjarne P, Anggard A, Lundberg JM (1988) Sympathetic vascular control of the pig nasal mucosa (2): Reserpine-resistant, non-adrenergic nervous responses in relation to neuropeptide Y and ATP. Acta Physiol Scand 133(2): 183–197

    PubMed  CAS  Google Scholar 

  23. Cervin A (1992) Neuropeptide Y 16-36 inhibits mucociliary activity but does not affect blood flow in the rabbit maxillary sinus in vivo. Regul Pept 39(2-3): 237–246

    Article  PubMed  CAS  Google Scholar 

  24. Lacroix JS, Ricchetti AP, Morel D, Mossimann B, Waeber B, Grouzmann E (1996) Intranasal administration of neuropeptide Y in man: systemic absorption and functional effects. Br J Pharmacol 118(8): 2079–2084

    PubMed  CAS  Google Scholar 

  25. Cervin A, Onnerfalt J, Edvinsson L, Grundemar L (1999) Functional effects of neuropeptide Y receptors on blood flow and nitric oxide levels in the human nose. Am J Respir Crit Care Med 160(5 Pt 1): 1724–1728

    PubMed  CAS  Google Scholar 

  26. Baraniuk JN, Silver PB, Kaliner MA, Barnes PJ (1992) Neuropeptide Y is a vasoconstrictor in human nasal mucosa. J Appl Physiol 73(5): 1867–1872

    PubMed  CAS  Google Scholar 

  27. Widdicombe JG (1990) The NANC system and airway vasculature. Arch Int Pharmacodyn Ther 303: 83–99

    PubMed  CAS  Google Scholar 

  28. Laitinen LA, Laitinen A, Salonen RO, Widdicombe JG (1987) Vascular actions of airway neuropeptides. Am Rev Respir Dis 136(6 Pt 2): S59–S64

    PubMed  CAS  Google Scholar 

  29. Salonen RO, Webber SE, Widdicombe JG (1988) Effects of neuropeptides and capsaicin on the canine tracheal vasculature in vivo. Br J Pharmacol 95(4): 1262–1270

    PubMed  CAS  Google Scholar 

  30. Matran R (1991) Neural control of lower airway vasculature. Involvement of classical transmitters and neuropeptides. Acta Physiol Scand (Suppl) 601: 1–54

    CAS  Google Scholar 

  31. Franco-Cereceda A, Matran R, Alving K, Lundberg JM (1995) Sympathetic vascular control of the laryngeo-tracheal, bronchial and pulmonary circulation in the pig: evidence for non-adrenergic mechanisms involving neuropeptide Y. Acta Physiol Scand 155(2): 193–204

    Article  PubMed  CAS  Google Scholar 

  32. Mullol J, Rieves RD, Baraniuk JN, Lundgren JD, Merida M, Hausfeld JH, Shelhamer JH, Kaliner MA (1992) The effects of neuropeptides on mucous glycoprotein secretion from human nasal mucosa in vitro. Neuropeptides 21(4): 231–238

    Article  PubMed  CAS  Google Scholar 

  33. Lacroix JS, Mosimann BL (1996) Attenuation of allergen-evoked nasal responses by local pretreatment with exogenous neuropeptide Y in atopic patients. J Allergy Clin Immunol 98(3): 611–616

    Article  PubMed  CAS  Google Scholar 

  34. Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T, Westfall T (1998) XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50(1): 143–150

    PubMed  CAS  Google Scholar 

  35. Grundemar L (1997) Characterization of the receptor response for the neuropeptide Yevoked suppression of parasympathetically-mediated contractions in the guinea pig trachea. Regul Pept 71(2): 97–101

    Article  PubMed  CAS  Google Scholar 

  36. Landis BN, Grouzman E, Lacroix JS (2005) Modulation of histamine induced bronchoconstriction after DPP IV pretreatment. Regul Pept; in press

    Google Scholar 

  37. Pernow J, Lundberg JM, Kaijser L, Hjemdahl P, Theodorsson-Norheim E, Martinsson A, Pernow B (1986) Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. Clin Physiol 6(6): 561–578

    PubMed  CAS  Google Scholar 

  38. Richerson HB, Seebohm PM (1968) Nasal airway response to exercise. J Allergy 41(5): 269–284

    Article  PubMed  CAS  Google Scholar 

  39. Dallimore NS, Eccles R (1977) Changes in human nasal resistance associated with exercise, hyperventilation and rebreathing. Acta Otolaryngol 84(5-6): 416–421

    PubMed  CAS  Google Scholar 

  40. Lacroix JS, Correia F, Fathi M, Grouzmann E (1997) Post-exercise nasal vasoconstriction and hyporeactivity: possible involvement of neuropeptide Y. Acta Otolaryngol 117(4): 609–613

    PubMed  CAS  Google Scholar 

  41. Stretton CD, Barnes PJ (1988) Modulation of cholinergic neurotransmission in guineapig trachea by neuropeptide Y. Br J Pharmacol 93(3): 672–678

    PubMed  CAS  Google Scholar 

  42. Matran R, Martling CR, Lundberg JM (1989) Inhibition of cholinergic and non-adrenergic, non-cholinergic bronchoconstriction in the guinea pig mediated by neuropeptide Y and alpha 2-adrenoceptors and opiate receptors. Eur J Pharmacol 163(1): 15–23

    Article  PubMed  CAS  Google Scholar 

  43. Lacroix JS, Ulman LG, Potter EK (1994) Sympathetic and parasympathetic interaction in vascular control of the nasal mucosa in anaesthetized cats. J Physiol 480(Pt 2): 325–331

    PubMed  CAS  Google Scholar 

  44. Potter EK, Barden JA, McCloskey MJ, Selbie LA, Tseng A, Herzog H, Shine J (1994) A novel neuropeptide Y analog, N-acetyl [Leu28,Leu31]neuropeptide Y-(24-36), with functional specificity for the presynaptic (Y2) receptor. Eur J Pharmacol 267(3): 253–262

    PubMed  CAS  Google Scholar 

  45. Lacroix JS, Ulman LG, Potter EK (1994) Modulation by neuropeptide Y of parasympathetic nerve-evoked nasal vasodilatation via Y2 prejunctional receptor. Br J Pharmacol 113(2): 479–484

    PubMed  CAS  Google Scholar 

  46. Herzog H, Hort YJ, Ball HJ, Hayes G, Shine J, Selbie LA (1992) Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc Natl Acad Sci USA 89(13): 5794–5798

    PubMed  CAS  Google Scholar 

  47. Revington M, Lacroix JS, Potter EK (1997) Sympathetic and parasympathetic interaction in vascular and secretory control of the nasal mucosa in anaesthetized dogs. J Physiol 505(Pt 3): 823–831

    PubMed  CAS  Google Scholar 

  48. Stretton CD, Belvisi MG, Barnes PJ (1990) Neuropeptide Y modulates non-adrenergic, non-cholinergic neural bronchoconstriction in vivo and in vitro. Neuropeptides 17(4): 163–170

    Article  PubMed  CAS  Google Scholar 

  49. Benchekroun TM, Fournier A, St-Pierre S, Cadieux A (1992) Inhibitory action of neuropeptide Y on agonist-induced responses in isolated guinea pig trachea. Eur J Pharmacol 216(3): 421–428

    CAS  Google Scholar 

  50. Grouzmann E, Buclin T, Martire M, Cannizzaro C, Dorner B, Razaname A, Mutter M (1997) Characterization of a selective antagonist of neuropeptide Y at the Y2 receptor. Synthesis and pharmacological evaluation of a Y2 antagonist. J Biol Chem 27(12): 7699–7706

    Google Scholar 

  51. Malis DD, Grouzmann E, Morel DR, Mutter M, Lacroix LS (1999) Influence of TASPV, a novel neuropeptide Y (NPY) Y2 agonist, on nasal and bronchial responses evoked by histamine in anaesthetized pigs and in humans. Br J Pharmacol 126(4): 989–996

    Article  PubMed  CAS  Google Scholar 

  52. Takahashi T, Ichinose M, Yamauchi H, Miura M, Nakajima N, Ishikawa J, Inoue H, Takishima T, Shirato K (1993) Neuropeptide Y inhibits neurogenic inflammation in guinea pig airways. J Appl Physiol 75(1): 103–107

    PubMed  CAS  Google Scholar 

  53. Nadelhaft I, Vera PL (1991) Neurons labelled after the application of tracer to the distal stump of the transected hypogastric nerve in the rat. J Auton Nerv Syst 36(2): 87–96

    Article  PubMed  CAS  Google Scholar 

  54. Fujiwara H, Kurihara N, Hirata K, Ohta K, Kanazawa H, Takeda T (1993) Effect of neuropeptide Y on human bronchus and its modulation of neutral endopeptidase. J Allergy Clin Immunol 92(1 Pt 1): 89–94

    PubMed  CAS  Google Scholar 

  55. Lacroix JS, Kurt AM, Pochon N, Bretton C, Lundberg JM, Deshusses J (1995) Neutral endopeptidase activity and concentration of sensory neuropeptide in the human nasal mucosa. Eur Arch Otorhinolaryngol 252(8): 465–468

    Article  PubMed  CAS  Google Scholar 

  56. Grouzmann E, Monod M, Landis B, Wilk S, Brakch N, Nicoucar K, Giger R, Malis D, Szalay-Quinodoz I, Cavadas C, et al. (2002) Loss of dipeptidylpeptidase IV activity in chronic rhinosinusitis contributes to the neurogenic inflammation induced by substance P in the nasal mucosa. FASEB J 16(9): 1132–1134

    PubMed  CAS  Google Scholar 

  57. Chung F (2001) Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-gamma. Mediators Inflamm 10(2): 51–59

    PubMed  CAS  Google Scholar 

  58. Kawamura N, Tamura H, Obana S, Wenner M, Ishikawa T, Nakata M, Yamamoto H (1998) Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets. Neuroimmunomodulation 5(1-2): 9–15

    Article  PubMed  CAS  Google Scholar 

  59. Bedoui S, Kawamura N, Straub RH, Pabst R, Yamamura T, von Horsten S (2003) Relevance of neuropeptide Y for the neuroimmune crosstalk. J Neuroimmunol 134(1-2): 1–11

    Article  PubMed  CAS  Google Scholar 

  60. Levite M (1998) Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proc Natl Acad Sci USA 95(21): 12544–12549

    Article  PubMed  CAS  Google Scholar 

  61. Levite M (2000) Nerve-driven immunity. The direct effects of neurotransmitters on Tcell function. Ann NY Acad Sci 917: 307–321

    CAS  Google Scholar 

  62. Bradding P (2003) The role of the mast cell in asthma: a reassessment. Curr Opin Allergy Clin Immunol 3(1): 45–50

    PubMed  CAS  Google Scholar 

  63. Groneberg DA, Welker P, Fischer TC, Dinh QT, Grutzkau A, Peiser C, Wahn U, Henz BM, Fischer A (2003) Down-regulation of vasoactive intestinal polypeptide receptor expression in atopic dermatitis. J Allergy Clin Immunol 111(5): 1099–1105

    Article  PubMed  CAS  Google Scholar 

  64. Mousli M, Trifilieff A, Pelton JT, Gies JP, Landry Y (1995) Structural requirements for neuropeptide Y in mast cell and G protein activation. Eur J Pharmacol 289(1): 125–133

    PubMed  CAS  Google Scholar 

  65. Emadi-Khiav B, Mousli M, Bronner C, Landry Y (1995) Human and rat cutaneous mast cells: involvement of a G protein in the response to peptidergic stimuli. Eur J Pharmacol 272(1): 97–102

    Article  PubMed  CAS  Google Scholar 

  66. Shen GH, Grundemar L, Zukowska-Grojec Z, Hakanson R, Wahlestedt C (1991) C-terminal neuropeptide Y fragments are mast cell-dependent vasodepressor agents. Eur J Pharmacol 204(3): 249–256

    Article  PubMed  CAS  Google Scholar 

  67. Cross LJ, Beck-Sickinger AG, Bienert M, Gaida W, Jung G, Krause E, Ennis M (1996) Structure activity studies of mast cell activation and hypotension induced by neuropeptide Y (NPY), centrally truncated and C-terminal NPY analogues. Br J Pharmacol 117(2): 325–332

    PubMed  CAS  Google Scholar 

  68. Grundemar L, Krstenansky JL, Hakanson R (1994) Neuropeptide Y and truncated neuropeptide Y analogs evoke histamine release from rat peritoneal mast cells. A direct effect on G proteins? Eur J Pharmacol 258(1-2): 163–166

    Article  PubMed  CAS  Google Scholar 

  69. Barnes PJ (2001) Cytokine modulators as novel therapies for airway disease. Eur Respir J Suppl 34: 67s–77s

    CAS  Google Scholar 

  70. Barnes PJ (2001) Cytokine modulators for allergic diseases. Curr Opin Allergy Clin Immunol 1(6): 555–560

    PubMed  CAS  Google Scholar 

  71. Bowler RP, Crapo JD (2002) Oxidative stress in airways: is there a role for extracellular superoxide dismutase? Am J Respir Crit Care Med 166(12 Pt 2): S38–S43

    PubMed  Google Scholar 

  72. Henricks PA, Nijkamp FP (2001) Reactive oxygen species as mediators in asthma. Pulm Pharmacol Ther 14(6): 409–420

    Article  PubMed  CAS  Google Scholar 

  73. De la Fuente M, Del Rio M, Medina S (2001) Changes with aging in the modulation by neuropeptide Y of murine peritoneal macrophage functions. J Neuroimmunol 116(2): 156–167

    PubMed  Google Scholar 

  74. Dimitrijevic M, Stanojevic S, Vujic V, Kovacevic-Jovanovic V, Beck-Sickinger A, Demuth H, von Horsten S (2002) Effect of neuropeptide Y on inflammatory paw edema in the rat: involvement of peripheral NPY Y1 and Y5 receptors and interaction with dipeptidyl-peptidase IV (CD26). J Neuroimmunol 129(1-2): 35–42

    Article  PubMed  CAS  Google Scholar 

  75. von Horsten S, Ballof J, Helfritz F, Nave H, Meyer D, Schmidt RE, Stalp M, Klemm A, Tschernig T, Pabst R (1998) Modulation of innate immune functions by intracerebroventricularly applied neuropeptide Y: dose and time dependent effects. Life Sci 63(11): 909–922

    Google Scholar 

  76. von Horsten S, Exton NG, Exton MS, Helfritz F, Nave H, Ballof J, Stalp M, Pabst R (1998) Brain NPY Y1 receptors rapidly mediate the behavioral response to novelty and a compartment-specific modulation of granulocyte function in blood and spleen. Brain Res 806(2): 282–286

    Google Scholar 

  77. von Horsten S, Nave H, Ballof J, Helfritz F, Meyer D, Schmidt RE, Stalp M, Exton NG, Exton MS, Straub RH, et al. (1998) Centrally applied NPY mimics immunoactivation induced by non-analgesic doses of met-enkephalin. Neuroreport 9(17): 3881–3885

    Google Scholar 

  78. Song C, Leonard BE (1998) Comparison between the effects of sigma receptor ligand JO 1784 and neuropeptide Y on immune functions. Eur J Pharmacol 345(1): 79–87

    Article  PubMed  CAS  Google Scholar 

  79. Straub RH, Schaller T, Miller LE, von Horsten S, Jessop DS, Falk W, Scholmerich J (2000) Neuropeptide Y cotransmission with norepinephrine in the sympathetic nervemacrophage interplay. J Neurochem 75(6): 2464–2471

    Article  PubMed  CAS  Google Scholar 

  80. Howarth PH, Springall DR, Redington AE, Djukanovic R, Holgate ST, Polak JM (1995) Neuropeptide-containing nerves in endobronchial biopsies from asthmatic and nonasthmatic subjects. Am J Respir Cell Mol Biol 13(3): 288–296

    PubMed  CAS  Google Scholar 

  81. Chanez P, Springall D, Vignola AM, Moradoghi-Hattvani A, Polak JM, Godard P, Bousquet J (1998) Bronchial mucosal immunoreactivity of sensory neuropeptides in severe airway diseases. Am J Respir Crit Care Med 158(3): 985–990

    PubMed  CAS  Google Scholar 

  82. Dahlof C, Dahlof P, Lundberg JM, Strombom U (1988) Elevated plasma concentration of neuropeptide Y and low level of circulating adrenaline in elderly asthmatics during rest and acute severe asthma. Pulm Pharmacol 1(1): 3–6

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unité de Rhinologie-Olfactologie, Service d’Oto-Rhino-Laryngologie, Hôpitaux Universitaires de Genève, Rue Micheli-du-Crest 24, 1211, Geneva, Switzerland

    Basile N. Landis, Isabelle Plouin-Gaudon & Jean-Silvain Lacroix

Authors
  1. Basile N. Landis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Isabelle Plouin-Gaudon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jean-Silvain Lacroix
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Physiology and Biophysics, Georgetown University Medical Center, 3900 Reservoir Rd., NW, Washington, DC, 20057, USA

    Zofia Zukowska

  2. Wyeth Research, Building A3153 500 Arcola Rd, Collegeville, PA, 19426, USA

    Giora Z. Feuerstein

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Birkhäuser Verlag Basel/Switzerland

About this chapter

Cite this chapter

Landis, B.N., Plouin-Gaudon, I., Lacroix, JS. (2005). NPY in allergic and respiratory disorders. In: Zukowska, Z., Feuerstein, G.Z. (eds) The NPY Family of Peptides in Immune Disorders, Inflammation, Angiogenesis and Cancer. Progress in Inflammation Research. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7427-6_7

Download citation

Publish with us

Policies and ethics

Search

Navigation